Martin Nielsen; Visionary Leader Driving Integrative Lyme Treatment at IAH Wellness

July 08 16:06 2025
Martin Nielsen; Visionary Leader Driving Integrative Lyme Treatment at IAH Wellness

Martin Nielsen is the CEO and co‑founder of IAH Wellness, based in Andorra, a pioneering immunotherapy clinic dedicated to treating Lyme disease and co‑infections using advanced, integrative protocols. Under his leadership, the company developed the LACI® protocol, reshaping chronic illness care for patients worldwide.

Early Inspiration & Mission

Nielsen’s motivation stems from seeing conventional medicine fall short when addressing complex, multi‑systemic illnesses like chronic Lyme. His driving mission: “Helping our patients get back on the path to a functional life is our greatest passion.”

The LACI® Protocol: A Synergistic Four‑Phase Approach

Under Martin Nielsen’s leadership, IAH Wellness designed LACI® (Lyme and Co‑Infections)—a science‑driven, four‑phase protocol structured to address Lyme complexity through:

Pre‑treatment (at home): Gentle detox, immune moderation, inflammation reduction.

Clinical Phase (on‑site): Includes Insulin Potentiation Therapy (IPT) to enhance IV antibiotic delivery, alongside fourth‑generation probiotics and targeted herbal therapies.

Post‑treatment (at home): A tailored regimen featuring oral antimicrobials, probiotics, ongoing supplements, with close remote monitoring to support recovery.

Long‑term Follow‑up: Spanning several months to consolidate gains and prevent relapse.

This deeply integrative model combines pharmacological precision with immune‑boosting naturopathic support—an innovation Nielsen champions as vital for chronic cases.

Impact & Clinical Success

IAH Wellness reports significant patient recoveries—even after years of misdiagnoses. Nielsen emphasizes that while Lyme is known as “the great imitator” and often goes undiagnosed for months or years, LACI® delivers hope through structured, immune‑supportive healing.

Leadership Style & Core Values

Nielsen’s leadership reflects three defining principles:

Innovation: Pioneering integrative therapies (IPT, advanced probiotics, herbal protocols) rarely offered elsewhere.

Personalization: Each treatment is customized to a patient’s immune status, exposure history, and symptom severity.

Empathy: Structured patient support from pre‑treatment through follow‑up fosters long‑term well‑being and restored functionality.

Global Outreach & Future Vision

Though headquartered in Andorra, Nielsen plans to expand IAH Wellness beyond Europe. By combining medical rigor with holistic modalities, he aims to make advanced integrative Lyme care accessible globally. His strategy includes:

Building international clinical partnerships.

Conducting outcome‑oriented research.

Elevating public awareness about Lyme’s complexity and diverse treatment needs.

“Being able to bring the treatment closer to the needed rather than the opposite where the suffering patient need to travel, many times intercontinentally, would be one of our mayor achievements,” says Nielsen.

Conclusion

Martin Nielsen’s leadership at IAH Wellness stands at the intersection of compassion, innovation, and rigorous medicine. Through his championing of the LACI® protocol, he offers a transformative approach for those suffering long‑term Lyme and co‑infections. As awareness and evidence grow, Nielsen’s vision may well redefine chronic Lyme care worldwide.

For more information about Martin Nielsen, IAH Wellness, or the LACI® protocol, visit www.iahwellness.com or follow @IAHWellness on social platforms.

Media Contact
Company Name: IAH Wellness
Contact Person: Press Office
Email: Send Email
Country: United States
Website: https://www.iahwellness.com

view more articles

About Article Author